D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $47.3M | 0.04% |
+698,781
| New | +$44.9M |
|
502
Nike
NKE
$61.9B
| $47.1M | 0.04% |
324,642
-601,400
| -65% | -$98.1M |
|
503
CALL
Okta
OKTA
$24.1B
| $47.1M | 0.04% |
198,600
+45,300
| +30% | +$11.2M |
|
504
PUT
Bristol-Myers Squibb
BMY
$127B
| $47M | 0.04% |
793,900
+260,800
| +49% | +$17.2M |
|
505
PUT
RingCentral
RNG
$4.05B
| $46.9M | 0.04% |
215,800
+78,200
| +57% | +$19.8M |
|
506
SolarEdge
SEDG
$2.59B
| $46.7M | 0.04% |
176,258
+118,529
| +205% | +$32.3M |
|
507
Magna International
MGA
$17.9B
| $46.7M | 0.04% |
621,748
+515,182
| +483% | +$42.4M |
|
508
TE Connectivity
TEL
$58.8B
| $46.7M | 0.04% |
340,302
-1,678
| -0.5% | -$242K |
|
|
XLRN
509
DELISTED
Acceleron Pharma
XLRN
| $46.7M | 0.04% |
271,291
+201,795
| +290% | +$26.4M |
|
510
Paycom
PAYC
$6.78B
| $46.7M | 0.04% |
94,144
-14,710
| -14% | -$6.56M |
|
|
SGEN
511
DELISTED
Seagen Inc. Common Stock
SGEN
| $46.5M | 0.04% |
273,656
-115,798
| -30% | -$18M |
|
512
GoPro
GPRO
$116M
| $46.4M | 0.04% |
4,957,692
-540,073
| -10% | -$5.46M |
|
513
Becton Dickinson
BDX
$43.1B
| $46.3M | 0.04% |
192,934
-27,877
| -13% | -$6.84M |
|
514
Appian
APPN
$1.74B
| $46.2M | 0.04% |
499,716
-161,833
| -24% | -$17.9M |
|
515
CALL
BILL Holdings
BILL
$4.33B
| $45.9M | 0.04% |
171,800
+124,500
| +263% | +$28.7M |
|
516
Flex
FLEX
$43.4B
| $45.6M | 0.04% |
3,422,309
-432,958
| -11% | -$5.82M |
|
517
PUT
Freeport-McMoran
FCX
$90B
| $45.5M | 0.04% |
1,398,300
-256,000
| -15% | -$9.01M |
|
518
LyondellBasell Industries
LYB
$19.5B
| $45.5M | 0.04% |
484,302
+463,846
| +2,268% | +$45.5M |
|
519
Teladoc Health
TDOC
$1.58B
| $45.4M | 0.04% |
358,030
+205,527
| +135% | +$29.9M |
|
520
PUT
Boston Beer
SAM
$1.88B
| $44.9M | 0.04% |
88,000
+48,000
| +120% | +$32.6M |
|
521
PUT
Charter Communications
CHTR
$14.7B
| $44.8M | 0.04% |
61,600
-4,000
| -6% | -$3.03M |
|
522
Labcorp
LH
$24.3B
| $44.8M | 0.04% |
185,304
-38,533
| -17% | -$9.71M |
|
523
DaVita
DVA
$15.1B
| $44.6M | 0.04% |
384,041
+207,096
| +117% | +$25.9M |
|
524
PTC Therapeutics
PTCT
$6.37B
| $44.6M | 0.04% |
1,199,533
-10,526
| -0.9% | -$432K |
|
525
PUT
Johnson & Johnson
JNJ
$635B
| $44.3M | 0.04% |
274,200
-71,600
| -21% | -$12.2M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.